MIR126: A Potential Drug Target Or Biomarker (G406913)

MIR126: A Potential Drug Target Or Biomarker

MIR126 (hsa-miR-126-5p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study, and several studies have investigated its role in various biological processes.

MIR126 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in a variety of tissues and cells and can interact with other molecules to regulate gene expression. The most well-studied miRNA family is the hsa-miR-126 family, which consists of 126 members in humans.

One of the unique features of MIR126 is its expression pattern. It is highly expressed in the brain and nervous system, and its levels are significantly reduced in various diseases, such as Alzheimer's disease, Parkinson's disease, and cancer. This makes it an attractive target for studying the role of miRNA in neurological and psychiatric diseases.

In addition to its expression pattern, MIR126 has also been shown to play a role in several cellular processes. For example, it has been shown to regulate the translation of pre-mRNA into protein, which is important for protein synthesis and cell growth. It has also been shown to play a role in cell survival and has been shown to be involved in the regulation of cell apoptosis, which is a natural process that helps the body eliminate damaged or dysfunctional cells.

MIR126 has also been shown to be involved in several signaling pathways. For example, it has been shown to be involved in the PI3K/Akt signaling pathway, which is a well-established signaling pathway that regulates cell survival and growth. It has also been shown to be involved in the TGF-β signaling pathway, which is involved in cell proliferation and differentiation.

In addition to its role in cellular processes, MIR126 has also been shown to be involved in several biological processes. For example, it has been shown to be involved in the regulation of gene expression, which is the process by which the instructions in a gene's DNA are used to build proteins. It has also been shown to be involved in the regulation of protein stability and has been shown to interact with several protein molecules, including Ku70 and p21.

MIR126 has also been shown to be involved in several diseases, including cancer. For example, several studies have shown that MIR126 is downregulated in various types of cancer, such as breast cancer, lung cancer, and colorectal cancer. This suggests that it may be a useful biomarker for cancer and that targeting it may be a potential therapeutic approach.

In addition to its potential as a drug target or biomarker, MIR126 is also of interest due to its unique structure. It is a small molecule that consists of only a few hundred amino acid residues and has a highly conserved core structure. This makes it a promising target for small molecules that can modulate its activity.

In conclusion, MIR126 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases. Its unique expression pattern and cellular processes make it an attractive target for researchers to study, and its role in several biological processes makes it a valuable tool for the study of neurodegenerative diseases and other conditions. Further research is needed to fully understand the role of MIR126 in these diseases and to develop effective therapies that target it.

Protein Name: MicroRNA 126

The "MIR126 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR126 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469